Physician profile
Shawn Aghili
NPI 1871531590
$8,343.07
in general payments reported to CMS, 2019-2025
36 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $768 · 2021: $4,448 · 2022: $608 · 2023: $594 · 2024: $634 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,460 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,460.48 |
| Education | $196.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,624.26 | 2021-2022 | |
| Glaxosmithkline, LLC. | $729.77 | 2019-2025 | Nucala, Trelegy Ellipta |
| Abbvie INC. | $618.60 | 2021-2025 | Avycaz |
| Allergan, INC. | $509.49 | 2019-2020 | |
| Astellas Pharma US INC | $504.72 | 2019-2025 | Ambisome |
| Viiv Healthcare Company | $388.15 | 2023-2024 | Dovato, Cabenuva, Apretude |
| Astrazeneca Pharmaceuticals LP | $270.28 | 2019-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.39 | 2020-2022 | |
| Harmony Biosciences LLC | $133.40 | 2020-2021 | |
| United Therapeutics Corporation | $131.68 | 2020-2023 | Orenitram |
| Amgen INC. | $129.47 | 2021-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $121.84 | 2025 | Opsumit, Uptravi |
| Advanced Respiratory, INC | $83.72 | 2020-2021 | |
| Gilead Sciences, INC. | $83.55 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $79.49 | 2019-2023 | Dificid, Delstrigo, Pifeltro |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $76.11 | 2023-2024 | Arikayce |
| Novartis Pharmaceuticals Corporation | $69.99 | 2022 | |
| Shionogi INC | $64.36 | 2022-2023 | Fetroja |
| Boston Scientific Corporation | $64.33 | 2024 | Coredx, Cre Pro |
| Resmed Corp | $60.00 | 2019 | |
| Electromed, INC. | $58.00 | 2021-2025 | Smartvest |
| Pulmonx Corporation | $43.93 | 2021-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Paratek Pharmaceuticals, INC. | $40.46 | 2020-2022 | |
| Inari Medical, INC. | $37.17 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Takeda Pharmaceuticals U.S.A., INC. | $36.07 | 2021 | |
| Jazz Pharmaceuticals INC. | $28.24 | 2025 | |
| Baxter Healthcare | $23.11 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Itamar Medical INC | $19.86 | 2025 | Watchpatone |
| Janssen Biotech, INC. | $19.40 | 2021 | |
| Grifols USA, LLC | $18.59 | 2020 | |
| Genentech USA, INC. | $17.00 | 2019 | |
| Fisher & Paykel Healthcare INC | $16.72 | 2019 | |
| Philips North America LLC | $14.45 | 2021 | |
| Emd Serono, INC. | $14.42 | 2023 | Serostim |
| Bayer Healthcare Pharmaceuticals INC. | $14.23 | 2021 | |
| Axsome Therapeutics, INC. | $12.82 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Aghili listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.